GlassScriptPhysician profile
Sarah Gambridge
NPI 1538538111
$8,320.77
in general payments reported to CMS, 2019-2025
46 companies · $2,646 in 2025
The $2,646 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,039 · 2022: $800 · 2023: $1,926 · 2024: $1,910 · 2025: $2,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,482.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,866.25 | 2021-2025 | |
| Pfizer INC. | $1,299.94 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,098.00 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $670.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $638.69 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $380.84 | 2021-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $272.50 | 2021-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $263.52 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $226.54 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.37 | 2021-2025 | Jardiance |
| Astellas Pharma US INC | $151.24 | 2023-2024 | Veozah, Myrbetriq |
| Dexcom, INC. | $97.41 | 2022-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $88.49 | 2024-2025 | Watchman Access System |
| Amarin Pharma, INC. | $88.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $83.98 | 2024-2025 | Gardasil 9, Capvaxive, M-M-R II |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Gambridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.